Patents
Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
09/2009
09/10/2009US20090227592 Compounds effecting glucokinase
09/10/2009US20090227591 Cyclopentene compounds
09/09/2009EP2097382A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of no synthase
09/09/2009CN101528714A Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one
09/09/2009CN101528713A Pyridazine derivatives
09/08/2009US7585976 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting
09/08/2009US7585974 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application
09/08/2009CA2314339C N-benzyl-3-indenylacetamide derivatives for treating neoplasia
09/03/2009US20090221546 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
09/03/2009US20090221529 Heterocycles and derivatives thereof and methods of manufacture and therapeutic use
09/02/2009EP2096108A1 Novel organic electroluminescent compounds and organic electroluminscent device using the same
09/02/2009EP2094662A1 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents
09/02/2009EP2094645A1 2-hydroxy-1,3-diaminopropane derivatives
09/02/2009CN101522638A Pyridizinone derivatives
09/01/2009US7582657 Vanilloid receptor ligands and their use in treatments
08/2009
08/27/2009WO2009103478A1 Pyridone and pyridazinone derivatives as mch antagonists
08/27/2009US20090215834 Heterocyclic inhibitors of mek and methods of use thereof
08/27/2009US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid
08/26/2009CN101516838A Soluble epoxide hydrolase inhibitors
08/25/2009US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes
08/25/2009US7579465 For treatment of picornavirus infections in mammals
08/25/2009US7579347 Vanilloid receptor ligands and their use in treatments
08/20/2009US20090209542 mitogen activated protein kinase inhibitors; 4-(2-Fluoro-4-(methylthio)phenylamino)-N-(2-hydroxyethoxy)-1-methyl-6-oxo-1,6-dihydropyridazine-3-carboxamide; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
08/19/2009EP2089385A2 Inhibitors of hepatitis c virus
08/19/2009CN101508677A Synthesis process of 6-methoxy pyridazine-3- carboxylic acid
08/19/2009CN101508676A Synthesis process of 6-methoxy pyridazine-3- carboxylic acid
08/18/2009US7576234 Synthesis of 2-alkyl amino acids
08/18/2009US7576072 Heterocyclic inhibitors of MEK and methods of use thereof
08/13/2009WO2005122682A3 Process for the preparation of esters of piperazic acid
08/13/2009US20090203702 INHIBITORS OF p38
08/12/2009EP2086999A1 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
08/12/2009EP2086967A2 Inhibitors of hepatitis c virus
08/12/2009EP2086944A1 Process for preparing difluoromethylpyrazolyl carboxylates
08/12/2009CN101506174A Caspase inhibitors based on pyridazinone scaffold
08/12/2009CN101506155A Biphenyl derivatives and their use in treating hepatitis C
08/11/2009US7572793 Tau protein kinase 1 inhibitors; treatment for neurodegenerative disorders; Alzheimer's Disease, Parkinson's disease, Pick's Disease, vision defects; antiischemic, antidiabetic, anticarcinogenic, antitumor agents, antidepressants
08/06/2009WO2009097306A1 Substituted pyridazine derivatives which have histamine h3 antagonist activity
08/06/2009WO2009054952A3 Small molecule inhibitors of parp activity
08/06/2009US20090197890 Pyridazine derivatives and their use as therapeutic agents
08/06/2009CA2712885A1 Substituted pyridazine derivatives which have histamine h3 antagonist activity
08/05/2009EP2085391A2 Inhibitors of factor XA and other serine proteases involved in the coagulation cascade
08/05/2009EP1509506B1 Pyridazine derivatives
08/05/2009EP1473289B1 Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
08/05/2009CN101501006A Pyridinone and pyridazinone derivatives as inhibitors of poly(ADP-ribose)polymerase (PARP)
08/04/2009US7569518 3-chloro-5-(4-chlorophenyl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine; 4,5-diphenyl-6-alkyl-,2H-pyridazin-3-one, 4-(2,6-difluoro-4-aminophenyl)-5-phenyl-6-alkylpyridazine, and 3,4-diphenyl-5-alkyl-5-hydroxy furanone intermediates; a fungicide controlling plant diseases for agriculture or gardening
08/04/2009US7569517 4-biphenyl-substituted pyrazolidin-3 5-diones pesticide agent and/or microbicide and/or herbicide
07/2009
07/30/2009US20090192136 Benzoyl-piperazine derivatives
07/29/2009EP2083014A2 Inhibitors of interleukin-1ß converting enzyme
07/29/2009EP2082743A2 Inhibitors of GSK-3 and crystal structures of GSK-3beta protein and protein complexes
07/29/2009EP1268443B1 2-hydroxy-mutilin carbamate derivatives for antibacterial use
07/29/2009CN101495459A Monoazole ligand platinum analogs
07/29/2009CN101492416A Compounds effecting glucokinase
07/28/2009US7566781 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
07/23/2009US20090187018 Manufacture of Pure Hydralazine Salts
07/23/2009US20090186155 Ink for ink-jet recording, ink cartridge, ink-jet recording apparatus, method of determining, and method of ink-jet recording
07/22/2009EP2079710A1 Caspase inhibitors based on pyridazinone scaffold
07/22/2009EP2079525A1 Calcium receptor modulating agents
07/22/2009CN101486683A Pyridazinones and triazinones and medicinal use thereof
07/21/2009US7563893 3-Phenyl-cinnoline analogue and antitumor agent using the same
07/21/2009US7563790 Pyridazine derivatives
07/16/2009US20090181973 Medicinal composition comprising 3-alkoxy-6-allylthiopyridazines for prevention or treatment of cancer of the pancreas
07/15/2009EP2077998A1 Phthalazine, aza- and diaza-phthalazine compounds and methods of use
07/15/2009EP2077997A1 Pyridazine derivatives
07/15/2009EP1529037B1 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
07/15/2009EP1426365B1 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
07/15/2009CN101484428A Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11b-HSD 1)
07/14/2009US7560463 Diaryl ethers as opioid receptor antagonists
07/09/2009WO2009086041A1 Herbicidal pyridazinone derivatives
07/09/2009US20090176789 Diazaspirodecane orexin receptor antagonists
07/09/2009US20090176774 Compounds and methods of use
07/09/2009US20090176765 Pyridinone and Pyridazinone Derivatives as Inhibitors of Poly (Adp-Ribose) Polymerase (Parp)
07/09/2009CA2707520A1 Herbicidal pyridazinone derivatives
07/08/2009CN101479238A Amine derivative having npyy5 receptor antagonist activity
07/08/2009CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof
07/08/2009CN100509759C Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
07/07/2009CA2539969C Process for the preparation of carboxylic acids of nitrogen-containing aromatic heterocyclic compounds
07/07/2009CA2461510C Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
07/07/2009CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
07/02/2009WO2009080314A1 Pyridazine derivatives useful as fungicides and for the treatment of cancer
07/02/2009WO2009079797A1 Compounds and method for treatment of cancer
07/02/2009CA2710039A1 Compounds and method for treatment of cancer
07/02/2009CA2709169A1 Pyridazine derivatives useful as fungicides and for the treatment of cancer
07/01/2009EP2074998A2 Use of cyclic bioisosteres of purine system derivatives for the treatment of diseases caused by disorders of nitrergic and dopaminergic systems
07/01/2009EP2074097A2 Compounds for treating proliferative disorders
07/01/2009EP1226127B1 Substituted phenyl sulfamoyl carboxamides
07/01/2009CN101472899A 2-substituted 4-benzylphthalazinone derivatives as histamine H1 and H3 antagonists
07/01/2009CN100506230C Vascular intimal hyperplasia inhibitor
06/2009
06/30/2009US7553976 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
06/30/2009US7553972 Benzamide inhibitors of the P2X7 receptor
06/30/2009US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/30/2009US7553964 Useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands; for example, 5-{4-[3-({2R}-2-methyl-pyrrolidin-1-yl)-cis-cyclobutyl]-phenyl}-pyrimidine
06/30/2009CA2307111C Novel pyridazine derivatives and drugs containing the same as the active ingredient
06/25/2009WO2009007856A3 Novel polymorph of atorvastatin calcium and use thereof for the preparation of amorphous atorvastatin calcium
06/25/2009US20090163501 Aurora kinase modulators and method of use
06/24/2009EP1781614B1 Compounds which potentiate glutamate receptor and uses thereof in medicine
06/23/2009USRE40793 treating conditions related to impairment of gastric emptying, gastromotility disorders; superior gastrokinetic properties; e.g. trans-4-amino-N-[(1-butyl-3-hydroxy-4-piperidinyl)methyl]-5-chloro-2,3-dihydro-7-benzofurancarboxamide
06/23/2009US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
06/18/2009US20090155187 Drug for inhibiting vascular intimal hyperplasia
06/17/2009EP2069312A2 Pyridizinone derivatives
06/17/2009EP2069305A2 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 85